Answer
Afinitor (everolimus) is indicated for patients with advanced renal cell carcinoma whose disease has progressed on or after VEGF-targeted therapy.
Sources for this answer
- Afinitor TabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 37Document updated
Sources checked